Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by QualityTeston Oct 07, 2020 8:58pm
184 Views
Post# 31684612

RE:RE:RE:RE:RE:Wtf

RE:RE:RE:RE:RE:WtfNot sure why the board's resident chicken littles are so upset about this PP.

How is anyone surprised that RVX needed to raise additional funds after reading the company's financials? If you're going to rake DM over the coals for not having a deal done by the end of the year, then perhaps actually give him until Dec. 31 before losing your minds?

The latest PP was done at the highest share price in recent memory, the highest warrant price, and has the shortest warrant expiration date. 

Hopefully it was done/is going to be done with Hepa/Ori or some other party that has inside access to what is happening and would have no reason to accept these terms unless they were convinced of good things to come.
<< Previous
Bullboard Posts
Next >>